BioCryst Pharmaceuticals
BCRX
#4920
Rank
โ‚ฌ1.75 B
Marketcap
6,81ย โ‚ฌ
Share price
-0.85%
Change (1 day)
9.28%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -1,16ย โ‚ฌ

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,29ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,19ย โ‚ฌ a decrease over its 2021 EPS that were of -0,92ย โ‚ฌ.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,16ย โ‚ฌ-2.49%
2022-1,19ย โ‚ฌ29.13%
2021-0,92ย โ‚ฌ-4.63%
2020-0,96ย โ‚ฌ10.2%
2019-0,88ย โ‚ฌ0%
2018-0,88ย โ‚ฌ25.64%
2017-0,70ย โ‚ฌ4%
2016-0,67ย โ‚ฌ27.12%
2015-0,53ย โ‚ฌ-13.24%
2014-0,61ย โ‚ฌ23.64%
2013-0,49ย โ‚ฌ-30.38%
2012-0,71ย โ‚ฌ-37.3%
2011-1,13ย โ‚ฌ65.79%
2010-0,68ย โ‚ฌ117.14%
2009-0,31ย โ‚ฌ-46.15%
2008-0,58ย โ‚ฌ-26.97%
2007-0,79ย โ‚ฌ-40.67%
2006-1,34ย โ‚ฌ48.51%
2005-0,90ย โ‚ฌ1%
2004-0,89ย โ‚ฌ38.89%
2003-0,64ย โ‚ฌ-25%
2002-0,86ย โ‚ฌ231.03%
2001-0,26ย โ‚ฌ-56.72%
2000-0,60ย โ‚ฌ102.83%
1999-0,29ย โ‚ฌ2.94%
1998-0,29ย โ‚ฌ-55.84%
1997-0,65ย โ‚ฌ11.59%
1996-0,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-2,77ย โ‚ฌ 115.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,57ย โ‚ฌ-299.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,35ย โ‚ฌ 82.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-0,18ย โ‚ฌ-86.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-1,36ย โ‚ฌ 5.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,88ย โ‚ฌ 202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-0,39ย โ‚ฌ-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-2,84ย โ‚ฌ 120.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-3,07ย โ‚ฌ 138.89%๐Ÿ‡บ๐Ÿ‡ธ USA